On June 15, 2020, Knowledge Ecology International (KEI) and the Union for Affordable Cancer Treatments (UACT) submitted joint comments to the National Institutes of Health regarding two prospective exclusive patent licenses: “Prospective Grant of an Exclusive Patent License: Development and… Continue Reading
Update: The NIH sent a response to our comments, available here. The response fails to address the glaring lack of information available regarding Retargeted Therapeutics. On June 8, 2020, Knowledge Ecology International and the Union for Affordable Cancer Treatment (UACT)… Continue Reading
On Thursday, 18 June 2020, the Senate Foreign Relations Committee convened a hearing on COVID-19 and U.S. International Pandemic Preparedness, Prevention, and Response. The witnesses called to provide testimony included: 1) James L. Richardson, Director, Office of Foreign Assistance, U.S.… Continue Reading
On June 3, 2020, the U.S. Government Accountability Office (GAO) sent KEI four questions about the transparency of the intellectual property HHS owns and how HHS manages those rights. On June 22, 2020, we sent this response. KEI response to… Continue Reading
On Friday, 19 June 2020, the World Trade Organization (WTO) convened an informal virtual Open-ended Meeting of the TRIPS Council. . The following statements were delivered by South Africa at the virtual open-ended informal meeting of the TRIPS Council. In… Continue Reading
On Thursday, 4 June 2020, the United Kingdom of Great Britain and Northern Ireland hosted the Global Vaccines Summit which successfully raised $US 8.8 billion for Gavi, the Vaccine Alliance – breaking the original fundraising target of $US 7.4 billion.… Continue Reading
On June 9, 2020, the World Trade Organization (WTO) Appellate Body circulated its reports relating to the Australia – Tobacco Plain Packaging cases. The reports issued the decision regarding the appeals brought by Honduras and the Dominican Republic against the… Continue Reading
On 14 May 2020, Bernd Lange, Chair of the European Parliament’s Committee on International Trade (INTA) wrote a letter to Phil Hogan (Commissioner for Trade, European Commission) on the “commercial aspects of intellectual property rights for medical products in the… Continue Reading